The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

Breast

Prostate & urology

Lung & pleura

Colorectal & gastro

Melanoma & skin

Head & neck

Ovary & gynaecology

+ -

Bone

Brain & nervous system

Haematology oncology

Hepatobiliary pancreatic

Paediatric

Neuroendocrine

Sarcomas

News

ecancer sources relevant oncology news from key institutes, journals, governments, NGOs and charities, along with commissioned pieces from our dedicated news team.

Surgical procedure helps cancer patients face themselves again

Surgical procedure helps cancer patients face themselves again

FDA approves sirolimus protein-bound particles for malignant perivascular epithelioid cell tumour

FDA approves sirolimus protein-bound particles for malignant perivascular epithelioid cell tumour

Hypoxia imaging and combination therapy aid immunotherapy treatment of solid tumours

Hypoxia imaging and combination therapy aid immunotherapy treatment of solid tumours

Optimising preoperative radiation therapy in high-risk sarcoma

Optimising preoperative radiation therapy in high-risk sarcoma

Percutaneous image-guided microwave and cryoablation for lung sarcoma

Percutaneous image-guided microwave and cryoablation for lung sarcoma

COVID-19 and cancer: Useful resources

COVID-19 and cancer: Useful resources

FDA grants accelerated approval to dostarlimab-gxly for dMMR advanced solid tumours

FDA grants accelerated approval to dostarlimab-gxly for dMMR advanced solid tumours

New research identifies cancer types with little survival improvements in adolescents

New research identifies cancer types with little survival improvements in adolescents

Researchers discover gene linked to bone cancer in children and identify potential novel therapy

Researchers discover gene linked to bone cancer in children and identify potential novel therapy

ASCO 2021: Two complete responses and response rate of 41% for people with synovial sarcoma reported at ASCO in phase 2 SPEARHEAD-1 trial

ASCO 2021: Two complete responses and response rate of 41% for people with synovial sarcoma reported...

Tweets by @ecancer

More from ecancer